Diseases, Conditions, Syndromes

Drugmaker Glaxo shuts down plant over Legionnaires' bacteria

Drugmaker GlaxoSmithKline shut down a plant Tuesday that produces inhaled medications after discovering the bacteria that causes Legionnaire's disease, a potentially fatal form of pneumonia.

Diseases, Conditions, Syndromes

Phase II trials underway for new single dose malaria treatment

Early research on a new malaria drug shows potential for a single dose treatment of the disease. The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials ...

Medications

FDA clears drug for leading form of cystic fibrosis

Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...

Medications

Endo to buy Par Pharmaceutical for $8.05 bn

Endo International will buy Par Pharmaceutical Holdings in a $8.05 billion deal that will strengthen Endo's generic drugs business, the companies said Monday.

Medications

California court sides with consumers in generic drug fight

In a win for consumers, the California Supreme Court ruled Thursday that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash ...

page 40 from 40